This HTML5 document contains 110 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.2450/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q91761707
rdf:type
wikibase:Item
schema:description
article scientifique publié en 2019 wetenschappelijk artikel наукова стаття, опублікована 5 серпня 2019 im August 2019 veröffentlichter wissenschaftlicher Artikel scientific article published on 05 August 2019 artículu científicu espublizáu n'agostu de 2019
p:P577
wds:Q91761707-7AA01132-5B58-47DA-94B9-C6C6CA435973
wdt:P577
2019-08-05T00:00:00Z
p:P2860
wds:Q91761707-27007195-3318-4843-BA09-3FFFB3A0C238 wds:Q91761707-33FBA00E-0A3A-43E9-9199-A749E4DD6857 wds:Q91761707-36D8F034-2EFC-4A78-8D2F-0CE9DB11F5DA wds:Q91761707-3F182245-12CB-4E22-AF53-A2C88AA2D1DE wds:Q91761707-40C1E148-F67A-48BA-9E5A-0ED30AC01890 wds:Q91761707-4342B428-55C1-4E6F-833F-011ACF0BD4CD wds:Q91761707-BB6B2DDE-9316-4AAC-A188-EEE2CAFDF5AE wds:Q91761707-C6D6A523-7022-4801-8694-62CB97BEEB08 wds:Q91761707-D410F35F-92EC-41C7-B130-1DD6D99DD907 wds:Q91761707-E4ED15BD-7544-4609-AA82-192D8F6B22B0 wds:Q91761707-8CEB17E5-B1F9-4F89-8F25-D0B7ED8F0D8E wds:Q91761707-8D193B21-533E-4923-9615-64C86AD54FCF wds:Q91761707-8D64B5BA-16EC-44EB-97DA-13DE73118059 wds:Q91761707-930C4D87-F9DC-4A04-A132-61DC06280D5B wds:Q91761707-AE4B9A59-7960-46F3-A66D-E0DEBA2CEA14 wds:Q91761707-ED7DBE7D-B574-4CE0-981E-BA9F94607E55 wds:Q91761707-EDF4A9CD-B969-423E-94CC-BA88D974C515 wds:Q91761707-F52EB519-9CC5-4862-8518-5F6878E06063 wds:Q91761707-FB2D4FD9-EA91-49B9-9C8B-59794540D77E wds:Q91761707-05D8DE1F-442B-4DF9-90B4-80F2FB367960 wds:Q91761707-06D422E5-856E-4031-9B93-6D3B062E003D wds:Q91761707-096D44D5-F63B-4D18-B45E-7CA05DB46599 wds:Q91761707-1AC1C971-9298-47E3-BF6B-B891614C15FB wds:Q91761707-1D40E3DD-939D-4A4B-BE0F-D42B9EDD7260 wds:Q91761707-1EF91300-F50B-4116-850E-91C8E5AFB390 wds:Q91761707-04A7D156-3BF0-450B-8883-EC138151D85F wds:Q91761707-480EDB65-1556-4589-BB08-0AA00C65F337 wds:Q91761707-6C16AE58-1726-4B1A-8C6F-EE5B7874AD0A wds:Q91761707-6E913132-1AD9-4207-8D7E-EF29C02FDFC6 wds:Q91761707-70C4B7C8-9A13-483B-8EBF-C8DA18B21B18
wdt:P2860
wd:Q34112793 wd:Q38152659 wd:Q38239698 wd:Q79162953 wd:Q83675646 wd:Q44050973 wd:Q53176831 wd:Q38744512 wd:Q33676857 wd:Q38070104 wd:Q42237378 wd:Q42608614 wd:Q37083973 wd:Q38423480 wd:Q92444709 wd:Q38021422 wd:Q37170640 wd:Q37688482 wd:Q40232721 wd:Q53676269 wd:Q36949416 wd:Q87414069 wd:Q33583520 wd:Q80853169 wd:Q54241040 wd:Q52480601 wd:Q61633550 wd:Q37031111 wd:Q27015133 wd:Q38584164
p:P2093
wds:Q91761707-DDE58368-9772-4765-9243-F849D76722DB wds:Q91761707-B48521AC-4D5E-4A48-8274-5C89FD566CD7 wds:Q91761707-5D37B215-0525-42FD-865B-54B1216AB2D7 wds:Q91761707-017B52C4-6ABA-4AD4-BEBD-665BAFCE4D00
wdt:P2093
Son Nghiem Tanja M Windegger Paul A Scuffham Yoke L Fung
rdfs:label
Primary immunodeficiency disease: a cost-utility analysis comparing intravenous vs subcutaneous immunoglobulin replacement therapy in Australia Primary immunodeficiency disease: a cost-utility analysis comparing intravenous vs subcutaneous immunoglobulin replacement therapy in Australia
skos:prefLabel
Primary immunodeficiency disease: a cost-utility analysis comparing intravenous vs subcutaneous immunoglobulin replacement therapy in Australia Primary immunodeficiency disease: a cost-utility analysis comparing intravenous vs subcutaneous immunoglobulin replacement therapy in Australia
schema:name
Primary immunodeficiency disease: a cost-utility analysis comparing intravenous vs subcutaneous immunoglobulin replacement therapy in Australia Primary immunodeficiency disease: a cost-utility analysis comparing intravenous vs subcutaneous immunoglobulin replacement therapy in Australia
p:P50
wds:Q91761707-96FD94A0-D35C-4474-AFFF-882BD6074708
wdt:P50
wd:Q55126789
p:P1476
wds:Q91761707-173084A1-4304-49F0-A784-F4244AEF5447
wdt:P1476
Primary immunodeficiency disease: a cost-utility analysis comparing intravenous vs subcutaneous immunoglobulin replacement therapy in Australia
p:P304
wds:Q91761707-D4E8AB7C-9F5A-4AAF-B64E-FF42A9A5E062
wdt:P304
96-105
p:P31
wds:Q91761707-1C187200-B978-4541-B426-9967FD9A45CA
wdt:P31
wd:Q13442814
p:P921
wds:Q91761707-772C439D-1019-4EC6-BAA7-3096A4E241BA wds:Q91761707-F06EC68A-29D2-474F-9210-91E522E2BD9A
wdt:P921
wd:Q3043160 wd:Q408
p:P698
wds:Q91761707-3c7f42af-73ce-4514-bcb7-3644b1e8e60c wds:Q91761707-6BA4B60F-80D7-4AA3-8F41-78D73EEFC396
wdtn:P698
n9:32271703
wdt:P698
32271703
p:P1433
wds:Q91761707-ECE323F2-1F95-4A72-A5D6-B5C2CE5FAE3E
wdt:P1433
wd:Q26842792
p:P433
wds:Q91761707-2A05D83B-9073-4E79-8BF4-8DE87AC4168D
p:P478
wds:Q91761707-E751D39E-8F3D-4021-98C0-AEB2D4E1B35A
wdt:P433
2
wdt:P478
18
p:P356
wds:Q91761707-6274EC98-B1D9-41F0-BBB7-D2BF63CB343B
wdtn:P356
n11:2019.0083-19
wdt:P356
10.2450/2019.0083-19
p:P932
wds:Q91761707-F064C656-6346-4917-8EDC-95DBF23C8C43
wdt:P932
7141942